FT. LAUDERDALE, FL--(Marketwired - January 14, 2014) - Ulthera, Inc.
announced today that its platform ultrasound technology, the Ulthera® System
, will be featured in three symposia at the American Academy of Cosmetic Surgery
(AACS) 30th Annual Scientific Meeting, Jan. 14-19, 2014 in Hollywood, Fla. at The Westin Diplomat Resort & Spa. Ulthera, Inc. is a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications.
Data from clinical studies evaluating Ultherapy, the non-invasive treatment in which the Ulthera System is used, will be discussed in the following sessions:
Symposium: Applications of Lasers, Fillers, and Toxins
Date/Time: Wednesday, Jan. 15th, 4:00 - 5:30pm ET
Location: Room 314
Data to be Presented: [Pilot Study] Evaluation of the Safety and Effectiveness of Micro-focused Ultrasound with Visualization (MFU-V) for the Treatment of Erythematotelangiectatic Rosacea.
Faculty Presenter: Mark Lupin, MD
Symposium: Choosing/Using Technologies: Clinical Outcomes
Date/Time: Thursday, Jan. 16th, 2:00 - 3:30pm ET
Location: Grand Ballroom West
Data to be Presented: Prospective, Multi-Center, Pivotal Trial Evaluating the Safety and Effectiveness of Micro-focused Ultrasound with Visualization (MFU-V) for Improvement in Lines and Wrinkles of the Décolleté.
Faculty Presenter: Sabrina Fabi, MD
Symposium: Facial Anti-aging
Date/Time: Friday, Jan. 17th, 2:00 - 3:30pm ET
Location: Atlantic 2
Data to be Presented: Evaluation of Micro-focused Ultrasound with Visualization (MFU-V) for Lifting and Tightening of Facial and Neck Skin Laxity Using a Customized, High-Density and Vectoring Treatment Approach.
Faculty Presenter: William Werschler, MD
The Ulthera® System is indicated for use as a non-invasive dermatologic aesthetic treatment to lift the eyebrow and lift lax submental (beneath the chin) and neck tissue.
Ulthera, Inc. is a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive U.S. FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is an FDA-cleared treatment to lift skin above the brow, on the neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company. For more information, visit www.ultherapy.com.